Literature DB >> 8604351

Regulation of ornithine decarboxylase gene expression by the Wilms' tumor suppressor WT1.

J A Moshier1, M Skunca, W Wu, S M Boppana, F J Rauscher, J Dosescu.   

Abstract

The importance of ornithine decarboxylase (ODC) to cell proliferation is underscored by the complex array of cell-specific mechanisms invoked to regulate its synthesis and activity. Misregulation of ODC has severe negative consequences on normal cell function, including the acquisition of tumorigenic growth properties by cells overexpressing ODC. We hypothesize that ODC gene expression is a candidate target for the anti-proliferative function of certain tumor suppressors. Here we show that the Wilms' tumor suppressor WT1 binds to multiple sites within the human ODC promoter, as determined by DNase I protection and methylation interference assays. The expression of WT1 in transfected HCT 116, NIH/3T3 and HepG2 cells represses activity of the ODC promoter controlling expression of a luciferase reporter gene. In contrast WT1 expression enhances ODC promoter activity in SV40-transfected HepG2 cells. Both the extent of modulation of ODC gene expression and the mediating WT1 binding elements are cell specific. Constructs expressing WT1 deletion mutants implicate two regions required for repressor function, as well as an intrinsic activation domain. Understanding the regulation of ODC gene expression by WT1 may provide valuable insights into the roles of both WT1 and ODC in development and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604351      PMCID: PMC145756          DOI: 10.1093/nar/24.6.1149

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  41 in total

1.  Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence.

Authors:  F J Rauscher; J F Morris; O E Tournay; D M Cook; T Curran
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

2.  Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus.

Authors:  J F Morris; S L Madden; O E Tournay; D M Cook; V P Sukhatme; F J Rauscher
Journal:  Oncogene       Date:  1991-12       Impact factor: 9.867

3.  Structural elements of ornithine decarboxylase required for intracellular degradation and polyamine-dependent regulation.

Authors:  L Ghoda; D Sidney; M Macrae; P Coffino
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

4.  The candidate Wilms' tumour gene is involved in genitourinary development.

Authors:  K Pritchard-Jones; S Fleming; D Davidson; W Bickmore; D Porteous; C Gosden; J Bard; A Buckler; J Pelletier; D Housman
Journal:  Nature       Date:  1990-07-12       Impact factor: 49.962

5.  Regulation of mouse ornithine decarboxylase gene expression in a macrophage-like cell line: synergistic induction by bacterial lipopolysaccharide and cAMP.

Authors:  S A Zheng; C M McElwain; S M Taffet
Journal:  Biochem Biophys Res Commun       Date:  1991-02-28       Impact factor: 3.575

6.  Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus.

Authors:  M A Harrington; B Konicek; A Song; X L Xia; W J Fredericks; F J Rauscher
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

7.  Position-independent, aberrant expression of the human ornithine decarboxylase gene in transgenic mice.

Authors:  M Halmekytö; L Alhonen; J Wahlfors; R Sinervirta; O A Jänne; J Jänne
Journal:  Biochem Biophys Res Commun       Date:  1991-10-15       Impact factor: 3.575

8.  Transcriptional repression mediated by the WT1 Wilms tumor gene product.

Authors:  S L Madden; D M Cook; J F Morris; A Gashler; V P Sukhatme; F J Rauscher
Journal:  Science       Date:  1991-09-27       Impact factor: 47.728

9.  Protein-DNA interactions in the cAMP responsive promoter region of the murine ornithine decarboxylase gene.

Authors:  J J Palvimo; L M Eisenberg; O A Jänne
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

Review 10.  Wilms' tumour as a paradigm for the relationship of cancer to development.

Authors:  K Pritchard-Jones; N D Hastie
Journal:  Cancer Surv       Date:  1990
View more
  5 in total

1.  Deficiency in WT1-targeting microRNA-125a leads to myeloid malignancies and urogenital abnormalities.

Authors:  N Tatsumi; N Hojo; O Yamada; M Ogawa; Y Katsura; S Kawata; E Morii; H Sakamoto; R Inaba; A Tsuda; I Fukuda; N Moriguchi; H Hasuwa; M Okabe; F Fujiki; S Nishida; H Nakajima; A Tsuboi; Y Oka; N Hosen; H Sugiyama; Y Oji
Journal:  Oncogene       Date:  2015-05-11       Impact factor: 9.867

2.  Transcription factor Sp3 antagonizes activation of the ornithine decarboxylase promoter by Sp1.

Authors:  A P Kumar; A P Butler
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

3.  Amine oxidase copper-containing 1 (AOC1) is a downstream target gene of the Wilms tumor protein, WT1, during kidney development.

Authors:  Karin M Kirschner; Julian F W Braun; Charlotte L Jacobi; Lucas J Rudigier; Anja Bondke Persson; Holger Scholz
Journal:  J Biol Chem       Date:  2014-07-17       Impact factor: 5.157

Review 4.  Mechanisms of transcriptional regulation by WT1 (Wilms' tumour 1).

Authors:  Eneda Toska; Stefan G E Roberts
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

5.  Growth-inhibitory effects of the chemopreventive agent indole-3-carbinol are increased in combination with the polyamine putrescine in the SW480 colon tumour cell line.

Authors:  E Ann Hudson; Lynne M Howells; Barbara Gallacher-Horley; Louise H Fox; Andreas Gescher; Margaret M Manson
Journal:  BMC Cancer       Date:  2003-01-14       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.